No Data
No Data
No Data
No Data
No Data
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough
CytomX Therapeutics, Inc. (NASDAQ:CTMX) shares have had a horrible month, losing 27% after a relatively good period beforehand. The recent drop has obliterated the annual return, with the share pri
Simply Wall StApr 27 08:39 ET
Here's Why We're Not Too Worried About CytomX Therapeutics' (NASDAQ:CTMX) Cash Burn Situation
Yahoo FinanceApr 25 10:34 ET
Express News | JP Morgan Upgrades CytomX Therapeutics to Neutral
Moomoo 24/7Apr 22 08:18 ET
CytomX Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/22/2024 — JP Morgan Upgrades Underweight → Neutral 03/12/2024 94.61% BMO Capital $3.3 → $3.25 Maintain
BenzingaApr 22 08:17 ET
Analysts Offer Insights on Healthcare Companies: Cyclo Therapeutics (CYTH), CytomX Therapeutics (CTMX) and Pacific Biosciences (PACB)
TipRanksApr 22 04:20 ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersRallybio (NASDAQ:RLYB) shares rose 31.9% to $2.15 during Wednesday's after-market session. The company's market cap stands at $81.2 million. Vera Therapeutics (NASDAQ:VERA) shares increased by
BenzingaApr 10 16:31 ET
No Data
No Data